MAP4K3 and hepatocellular carcinoma: Wu et al. showed that Yiqi Jianpi Jiedu formula exerts its anti-HCC effect of HCC by β-catenin, mitogen-activated protein kinase 3 (MAPK3), PI3K/AKT pathway and ras homolog family member A (RHOA) [10].